If we cataloged and analyzed data from pre-clinical animal experiments, we might better understand 1) the inefficency and poor predictive value of animal tests, and 2) the risks that participants in early stage trials face.
http://www.nature.com/news/2006/060515/full/060515-16.html
May 22, 2006
OT - WHO quashes requests for continued secrecy in drug trials�-�Early stages of testing should be made public, say public-health experts.
posted at 10:25 AM
Labels: Ethics, pharma Hotlinks: DiggIt! Del.icio.us
Subscribe to:
Post Comments (Atom)
0 Comments:
Post a Comment